234 related articles for article (PubMed ID: 24171482)
1. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.
Ababneh N; Alshaer W; Allozi O; Mahafzah A; El-Khateeb M; Hillaireau H; Noiray M; Fattal E; Ismail S
Nucleic Acid Ther; 2013 Dec; 23(6):401-7. PubMed ID: 24171482
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
3. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
[TBL] [Abstract][Full Text] [Related]
4. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.
Somasunderam A; Thiviyanathan V; Tanaka T; Li X; Neerathilingam M; Lokesh GL; Mann A; Peng Y; Ferrari M; Klostergaard J; Gorenstein DG
Biochemistry; 2010 Oct; 49(42):9106-12. PubMed ID: 20843027
[TBL] [Abstract][Full Text] [Related]
6. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
7. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
[TBL] [Abstract][Full Text] [Related]
8. CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.
Chen F; Hu Y; Li D; Chen H; Zhang XL
PLoS One; 2009 Dec; 4(12):e8142. PubMed ID: 19997645
[TBL] [Abstract][Full Text] [Related]
9. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract][Full Text] [Related]
10. Development of DNA aptamers using Cell-SELEX.
Sefah K; Shangguan D; Xiong X; O'Donoghue MB; Tan W
Nat Protoc; 2010 Jun; 5(6):1169-85. PubMed ID: 20539292
[TBL] [Abstract][Full Text] [Related]
11. Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX.
Hung LY; Wang CH; Che YJ; Fu CY; Chang HY; Wang K; Lee GB
Sci Rep; 2015 May; 5():10326. PubMed ID: 25999049
[TBL] [Abstract][Full Text] [Related]
12. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
13. Capture and detection of Staphylococcus aureus with dual labeled aptamers to cell surface components.
Ramlal S; Mondal B; Lavu PS; N B; Kingston J
Int J Food Microbiol; 2018 Jan; 265():74-83. PubMed ID: 29132030
[TBL] [Abstract][Full Text] [Related]
14. Selection of an aptamer against mouse GP2 by SELEX.
Hanazato M; Nakato G; Nishikawa F; Hase K; Nishikawa S; Ohno H
Cell Struct Funct; 2014; 39(1):23-9. PubMed ID: 24334484
[TBL] [Abstract][Full Text] [Related]
15. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
16. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.
Lo CW; Chan CKW; Yu J; He M; Choi CHJ; Lau JYW; Wong N
Nanotheranostics; 2022; 6(2):161-174. PubMed ID: 34976591
[No Abstract] [Full Text] [Related]
17. Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX.
Kunii T; Ogura S; Mie M; Kobatake E
Analyst; 2011 Apr; 136(7):1310-2. PubMed ID: 21321690
[TBL] [Abstract][Full Text] [Related]
18. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
Shangguan D; Cao ZC; Li Y; Tan W
Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
20. Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.
Park HY; Lee KJ; Lee SJ; Yoon MY
Mol Biotechnol; 2012 Jul; 51(3):212-20. PubMed ID: 21979823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
